This webinar focuses on the use of novel pharmacological treatment strategies aimed at improving cardiovascular outcomes in medium to high-risk patients. The focus will be on newer lipid lowering agents and novel antidiabetic drugs as well as on gaining insight into newer markers of cardiovascular risk, such as high Lp(a). DOACs and antiplatelet agents will be also discussed in the context of cardiovascular events prevention. The aim of the programme is to increase awareness as to the new advances in lipid lowering treatment and identify those patient subgroups who should benefit the most from these new therapies. The programme will be practical, clinically driven, informative and interactive and of interest to a range of healthcare professionals.